IL10 and breast carcinoma: Moreover, CD200fc, which mimics the effect of CD200, significantly decreased tumor growth and metastasis in a mouse model of breast cancer, increased IFN-γ and decreased IL-6 expression, and time-dependently altered IL-10 and IL-17 levels [22].